menu
    • menu

    Company profile for SOM Biotech

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2009, SOM has developed all through the years a unique business model based on the know-how and expertise of talented people, always driven by curiosity, excellence and an instinct of self-improvement. We use Artificial Intelligence to bring therapeutic solutions to the patients without a time-consuming and ineffective R&D process.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SOM BiotechSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Baldiri Reixac, 4 (08028) Barcelona
    Telephone
    Telephone
    +34 934 020 150
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sombiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/som-biotech
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/sombiotech?lang=es

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SOM Biotech Advances SOM3355 For Huntington's Disease With FDA
    SOM Biotech Advances SOM3355 For Huntington's Disease With FDA

    20 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-20/som-biotech-secures-clear-registrational-path-for-som3355-in-huntington-s-disease-after-fda-end-of-p

    PHARMIWEB
    20 Oct 2025
    Share Share
    SOM Biotech Gets EMA COMP Nod for SOM3355 in Huntington's Disease
    SOM Biotech Gets EMA COMP Nod for SOM3355 in Huntington's Disease

    15 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-15/som-biotech-receives-positive-ema-comp-opinion-on-european-orphan-drug-designation-for-som3355-for-t

    PHARMAWEB
    15 Sep 2025
    Share Share
    SOM Biotech signs licensing agreement with the University of Minnesota
    SOM Biotech signs licensing agreement with the University of Minnesota

    16 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/16/2443425/0/en/SOM-Biotech-signs-licensing-agreement-with-the-University-of-Minnesota.html

    GLOBENEWSWIRE
    16 May 2022
    Share Share
    SOM Biotech granted Orphan Drug Designation by the FDA for SOM3355
    SOM Biotech granted Orphan Drug Designation by the FDA for SOM3355

    18 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/18/2315307/0/en/SOM-Biotech-granted-Orphan-Drug-Designation-by-the-FDA-for-SOM3355.html

    GLOBENEWSWIRE
    18 Oct 2021
    Share Share
    SOM Biotech presents positive Phase 2a data with SOM3355 at the 34th
    SOM Biotech presents positive Phase 2a data with SOM3355 at the 34th

    04 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/04/2307518/0/en/SOM-Biotech-presents-positive-Phase-2a-data-with-SOM3355-at-the-34th-ECNP-Congress-2021.html

    GLOBENEWSWIRE
    04 Oct 2021
    Share Share
    SOM Biotech presents positive Phase 2a data with SOM3355 at the 34th
    SOM Biotech presents positive Phase 2a data with SOM3355 at the 34th

    04 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/04/2307518/0/en/SOM-Biotech-presents-positive-Phase-2a-data-with-SOM3355-at-the-34th-ECNP-Congress-2021.html

    GLOBENEWSWIRE
    04 Oct 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search